Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Jul;24(1):132–133. doi: 10.1128/aac.24.1.132

Minimal inhibitory concentrations of lucknomycin, a new polyenic derivative, for Candida and Aspergillus spp.

J Martínez-Quesada, J M Torres-Rodriguez, M Rosés-Codinachs, M Amaral-Olivera
PMCID: PMC185117  PMID: 6625552

Abstract

The minimal inhibitory concentrations (MICs) of lucknomycin, a new polyenic derivative, were determined for 101 clinical isolates of Candida, 38 clinical or environmental strains of Aspergillus fumigatus, and 30 isolates of A. niger. The most susceptible species were Candida albicans and Candida tropicalis (mean MIC, 0.4 micrograms/ml). Aspergillus spp. were less susceptible, with mean MICs of 0.60 micrograms/ml for Aspergillus niger and 9.2 micrograms/ml for Aspergillus fumigatus.

Full text

PDF
132

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannatyne R. M., Cheung R. Comparative susceptibility of Candida albicans to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother. 1977 Oct;12(4):449–450. doi: 10.1128/aac.12.4.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brandsberg J. W., French M. E. In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B. Antimicrob Agents Chemother. 1972 Nov;2(5):402–404. doi: 10.1128/aac.2.5.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gadebusch H. H., Pansy F., Klepner C., Schwind R. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice. J Infect Dis. 1976 Nov;134(5):423–427. doi: 10.1093/infdis/134.5.423. [DOI] [PubMed] [Google Scholar]
  4. Kitahara M., Seth V. K., Medoff G., Kobayashi G. S. Antimicrobial susceptibility testing of six clinical isolates of Aspergillus. Antimicrob Agents Chemother. 1976 Jun;9(6):908–914. doi: 10.1128/aac.9.6.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Martinez J., Torres J. M., Arteaga F., Foz-Tena A. Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus. Mycopathologia. 1978 Nov 10;64(3):147–151. doi: 10.1007/BF00576365. [DOI] [PubMed] [Google Scholar]
  6. Montgomerie J. Z., Edwards J. E., Jr, Guze L. B. Synergism of amphotericin B and 5-fluorocytosine for candida species. J Infect Dis. 1975 Jul;132(1):82–86. doi: 10.1093/infdis/132.1.82. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES